Softer, harder, or just right? new ultrasound technique could spot breast cancer without a needle
NCT ID NCT04863443
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new ultrasound-based imaging method called Nonlinear Elasticity Mapping (NEM) to help tell apart benign and cancerous breast lumps. Researchers measured how breast tissue stretches and compresses, looking for patterns that match cancer. 172 women with breast findings on ultrasound took part. The goal was to see if NEM could reduce unnecessary biopsies by providing clearer information about a mass.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mayo Clinic Cancer Center
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?